Provectus Biopharmaceuticals, Inc (PVCT) insider trading
Every open-market stock purchase and sale by Provectus Biopharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Edward Pershing (CEO), $100K, 8 months ago.
Last 12 months: insiders bought $100K (1 buy) and sold $0 (0 sales). Last close $0.06 on Jun 7, 2026.
Recent PVCT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | Webster Bailey (Director) | Bought (not open market) | — |
| Jun 30, 2026 | Dominic Rodrigues (President) | Bought (not open market) | — |
| Jun 30, 2026 | John Lacey III (Director) | Bought (not open market) | — |
| Jun 5, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| May 28, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| May 23, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| May 15, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| May 7, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Apr 29, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Apr 4, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Mar 25, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Mar 20, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Mar 12, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Mar 5, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Feb 26, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Feb 20, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Feb 19, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Feb 12, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Feb 9, 2026 | Edward Pershing (CEO) | Bought | $100K |
| Feb 5, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Jan 30, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Jan 28, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Jan 16, 2026 | Edward Pershing (CEO) | Bought (not open market) | — |
| Dec 11, 2025 | Edward Pershing (CEO) | Bought (not open market) | — |
| Dec 5, 2025 | Edward Pershing (CEO) | Bought (not open market) | — |
Who's trading PVCT
- Webster Bailey, Director: other filings, last Jun 30, 2026
- John Lacey III, Director: other filings, last Jun 30, 2026
- Dominic Rodrigues, President: other filings, last Jun 30, 2026
- Edward Pershing, CEO: bought $100K (1 buy), last Jun 5, 2026
Get free alerts when an insider at Provectus Biopharmaceuticals, Inc files a new trade →